EP 2097139 A1 20090909 - 2-{[2-(SUBSTITUTED AMINO)ETHYL]SULFONYL}ETHYL N,N,N',N'-TETRAKIS(2 -CHLOROETHYL)PHOSPHORODIAMIDATES
Title (en)
2-{[2-(SUBSTITUTED AMINO)ETHYL]SULFONYL}ETHYL N,N,N',N'-TETRAKIS(2 -CHLOROETHYL)PHOSPHORODIAMIDATES
Title (de)
2-{[2-(SUBSTITUIERTE AMINO)ETHYL]SULFONYL}ETHYL N,N,N',N'-TETRAKIS(2 -CHLOROETHYL)PHOSPHORODIAMIDATE
Title (fr)
N,N,N',N'-TÉTRACIS(2-CHLOROÉTHYL)PHOSPHORODIAMIDATES DE 2-{[2-(AMINO SUBSTITUTÉ)ÉTHYL]SULFONYL}ÉTHYLE
Publication
Application
Priority
US 2006045717 W 20061129
Abstract (en)
[origin: WO2008066526A1] 2-{[2-(Substituted amino)ethyl]sulfonyl}ethyl N,N,N',N' -tetrakis(2-chloroethyl)-phosphorodiamidates, their preparation and intermediates in their preparation, pharmaceutical compositions containing them, and methods of treatment using them. The compounds are useful for treating cancer, alone and in combination with other anticancer therapies (I).
IPC 8 full level
A61P 35/04 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); A61P 35/04 (2017.12); C07F 9/2408 (2013.01); C07F 9/572 (2013.01); C07F 9/59 (2013.01)
Citation (search report)
See references of WO 2008066526A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2008066526 A1 20080605; AU 2006351255 A1 20080605; CA 2670628 A1 20080605; CN 101553282 A 20091007; EP 2097139 A1 20090909; JP 2010511040 A 20100408; MX 2009005750 A 20090714
DOCDB simple family (application)
US 2006045717 W 20061129; AU 2006351255 A 20061129; CA 2670628 A 20061129; CN 200680056468 A 20061129; EP 06844637 A 20061129; JP 2009539222 A 20061129; MX 2009005750 A 20061129